These data strongly indicate that the eight peptides induce HLA-DR restricted responses. It should be noticed that the presence of IVA12 does not affect HLA class I restricted responses and the presence of anti-DR antibody does not affect HLA-DP restricted responses.28 A recently selleck chemicals llc developed assay for peptide binding to recombinant HLA-DR molecules was employed.32 Fourteen recombinant HLA-DR subtypes, representing

33% of all HLA-DR subtypes expressed by the PPD+ donors (Table 2), were assayed for binding of the eight antigenic peptides. However, only three of the eight M. tuberculosis peptides showed binding to HLA-DR subtypes (DRB1*0806, 1*1201, 1*1202), but none of these HLA-DR molecules was expressed by the two donors (no. 19 and 32) who showed reactivity for the three peptides (data not included). To obtain direct evidence of the phenotype of M. tuberculosis-peptide-reactive

cells, anti-M. tuberculosis reactivity was tested in PBMC depleted of CD4+ T cells before peptide exposure in expansion cultures. As shown in Fig. 2, CD4+ T-cell depletion resulted in a total loss of peptide reactivity in all but one (anti-TB Dabrafenib molecular weight 60 peptide reactivity) of the CD4+ T-cell-depleted PBMC fractions. To further validate that the ELISPOT responses were in fact a CD4+ T-cell response and not a mixture of CD4+ and CD8+ T-cell responses, we used a flow cytometry-based intracellular cytokine secretion assay. Two donors were analysed in this

assay, Donor 32 stimulated with TB2, TB88 and TB92, and donor 28 stimulated with TB60. After 10 days in vitro restimulation the cells were analysed by intracellular cytokine secretion. For all combinations a low but clear CD4+ T-cell response could be measured, with peptide TB2 and TB92 peptide recognized by donor 32 showing the highest frequency of CD4+-specific T cells (> 1%) (Fig. 3). In all cases no measurable peptide-specific CD8+ T-cell responses could be detected. For the peptide responses in donor 32 this correlates with the finding that the specific ELISPOT response was absent after CD4+ depletion (Fig. 2). The peptide T60 response in donor 28 could only be partially removed by CD4+ depletion (about 30% resides) but only a peptide-specific Glycogen branching enzyme CD4+ T-cell response and no CD8+ T-cell response could be detected by intracellular cytokine secretion. The aim of the present study was to identify CD8+ T-cell epitopes derived from M. tuberculosis using immuno-bioinformatics. We have previously used such an approach to successfully identify T-cell epitopes derived from smallpox virus and influenza A virus.26,27 However, in our previous study 39 and a more recent observation,28 it was shown that HLA-I binding 9mer peptides were able to induce CD4+ T-cell-dependent responses that apparently are restricted by the HLA-II molecules.